1Centre for Nutrition,Department of Clinical Medicine,University of Bergen,Bergen,Norway.
3Department of Rehabilitation,Nutrition and Sport,La Trobe University,Melbourne,Australia.
Nutr Res Rev. 2019 Jun;32(1):28-37. doi: 10.1017/S095442241800015X. Epub 2018 Jul 16.
The spectrum of gluten-related disorders includes coeliac disease (CD), wheat allergy (WA) and the suggested entity of non-coeliac gluten sensitivity (NCGS). An increasing number of the world's population are avoiding gluten due to the assumption of health benefits and self-diagnosed gastrointestinal and/or extra-intestinal symptoms. Unlike CD and WA, NCGS is a relatively new entity with an unknown prevalence and mechanisms, complicated by recent literature suggesting that gluten is not the only food component that may trigger symptoms experienced by this group of patients. The term 'non-coeliac wheat sensitivity' has been proposed as a more accurate term, allowing inclusion of other non-gluten wheat components such as fructans and amylase-trypsin inhibitors. There is inconsistent evidence when evaluating the effects of a gluten challenge in patients with suspected NCGS and there is a need for a standardised procedure to confirm the diagnosis, ultimately enabling the optimisation of clinical care. The present review will give an overview of the different gluten-related disorders and discuss the most recent scientific evidence investigating NCGS.
gluten 相关疾病谱包括乳糜泻(CD)、小麦过敏(WA)和非乳糜泻麸质敏感性(NCGS)这一假设实体。由于人们认为摄入麸质对健康有益以及自我诊断出胃肠道和/或肠外症状,越来越多的世界人口正在避免摄入麸质。与 CD 和 WA 不同,NCGS 是一个相对较新的实体,其患病率和发病机制尚不清楚,最近的文献表明,麸质并不是唯一可能引发这组患者症状的食物成分,这使得情况更加复杂。有人提出“非乳糜泻小麦敏感性”这个更准确的术语,以纳入其他非麸质小麦成分,如低聚果糖和淀粉酶-胰蛋白酶抑制剂。在评估疑似 NCGS 患者的麸质挑战的影响时,证据并不一致,因此需要制定标准化程序来确认诊断,最终能够优化临床治疗。本文将概述不同的 gluten 相关疾病,并讨论最近关于 NCGS 的科学证据。